These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24119112)

  • 61. Pilot study of bisoprolol 8mg transdermal patch at bedtime before coronary computed tomography angiography.
    Yamazaki D; Shimura Y; Enjoji Y; Nishinaga M; Kanmatuse K; Endo M
    J Cardiol; 2020 Apr; 75(4):394-399. PubMed ID: 31627998
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effects of bisoprolol and ramipril on short-term variability of systolic blood pressure during mental stress test: spectrum analysis].
    Elkohen M; Clerson P; Mounier-Véhier C; Gressin V; Humbert R; Carré A
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1075-80. PubMed ID: 8572849
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril.
    Breed JG; Ciampricotti R; Tromp GP; Valster FA; Lageweg E; Van Bortel LM
    J Cardiovasc Pharmacol; 1992; 20(5):750-5. PubMed ID: 1280737
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study.
    Shimamoto K; Hasebe N; Ito S; Kario K; Kimura K; Dohi Y; Kawano Y; Rakugi H; Horiuchi M; Imaizumi T; Ohya Y
    Hypertens Res; 2014 Jan; 37(1):69-75. PubMed ID: 23945965
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R; Maclean D; Ioannides C; Johnston A; McDevitt DG
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The effect long-term administration of a selective beta1 blocker bisoprolol on glucose metabolism in patients with essential hypertensive and type 2 diabetes mellitus].
    Wang B; Song WH; Liu GZ;
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):503-5. PubMed ID: 16080839
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The blood pressure lowering effect of bisoprolol, a beta 1-selective receptor blocker--a multicenter study in general practice conditions].
    Haustein KO
    Z Gesamte Inn Med; 1993 Oct; 48(10):476-9. PubMed ID: 8256466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.
    Prisant LM; Neutel JM; Ferdinand K; Papademetriou V; DeQuattro V; Hall WD; Weir MR
    J Natl Med Assoc; 1999 Jan; 91(1):40-8. PubMed ID: 10063787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS; Thomas P; Sheridan DJ
    Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension.
    Paterna S; Parrinello G; Di Pasquale P; Torres D; La Rocca G; Antona R; Vernuccio L; Fornaciari E; Tarantino A; Piccione E; Fasullo S; Licata G
    Adv Ther; 2007; 24(6):1260-70. PubMed ID: 18165208
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [The clinical efficiency and safety of bisoprolol hydrochlorothiazide in patients with mild to moderate essential hypertension].
    Jiang H; Ke YN;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):605-8. PubMed ID: 17081362
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.
    Hong SJ; Ahn TH; Baek SH; Cho WH; Jeon HK; Kwan J; Yoon MH; Lee KJ; Lim DS
    Clin Ther; 2006 Apr; 28(4):537-51. PubMed ID: 16750465
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension].
    Widimský J
    Vnitr Lek; 2015 Dec; 61(12):1067-71. PubMed ID: 26806502
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study.
    Rakugi H; Enya K; Sugiura K; Ikeda Y
    Hypertens Res; 2012 May; 35(5):552-8. PubMed ID: 22278628
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
    Chow CK; Atkins ER; Hillis GS; Nelson MR; Reid CM; Schlaich MP; Hay P; Rogers K; Billot L; Burke M; Chalmers J; Neal B; Patel A; Usherwood T; Webster R; Rodgers A;
    Lancet; 2021 Sep; 398(10305):1043-1052. PubMed ID: 34469767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
    Lacourcière Y; Pool JL; Svetkey L; Gradman AH; Larochelle P; de Champlain J; Smith WB
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):454-61. PubMed ID: 9607384
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential effects of oral beta blockade on cardiovascular and sympathetic regulation.
    Beloka SP; Gouveia S; Gujic M; Naeije R; Rocha AP; van de Borne P
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):323-31. PubMed ID: 19903982
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
    Bühler FR; Berglund G; Anderson OK; Brunner HR; Scherrer U; van Brummelen P; Distler A; Philipp T; Fogari R; Mimran A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S122-7. PubMed ID: 2439782
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.
    Heagerty AM; Mallion JM
    Drugs Aging; 2009; 26(1):61-76. PubMed ID: 19102515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.